{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Shanhua Fang"}, {"accession": "MS:1000589", "name": "contact email", "value": "shanhua125@163.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Chinese Academy of Sciences Shanghai Institute of Materia Medica"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Hu ZHOU"}, {"accession": "MS:1000589", "name": "contact email", "value": "zhouhu@simm.ac.cn"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Chinese Academy of Sciences Shanghai Institute of Materia Medica"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/txt.zip"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-1.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-10.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-11.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-12.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-13.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-14.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-4.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-5.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-6.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-7.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-8.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_1-9.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-1.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-10.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-11.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-12.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-13.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-14.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-2.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-4.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-5.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-6.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-7.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-8.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975/20150716_TaizhouH_iTRAQ_Serum_2-9.raw"}], "description": "0.01). Moreover, receiver operating characteristic (ROC) curve analysis revealed high diagnostic value of these candidates in assessing HBV-ACLF. In conclusion, present quantitative proteomic study identified 6 novel HBV-ACLF biomarker candidates and might provide fundamental information for development of HBV-ACLF biomarker.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/10/PXD007975"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD007975"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD007975"}], "instruments": [{"accession": "MS:1001910", "name": "LTQ Orbitrap Elite"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "HBV-ACLF, CHB, iTRAQ, proteomics, biomarker."}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "PRIDE:0000398", "name": "No PTMs are included in the dataset"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "29270132"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Zhou N, Wang K, Fang S, Zhao X, Huang T, Chen H, Yan F, Tang Y, Zhou H, Zhu J. Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus. Front Physiol. 2017 8:1009"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Quantitative Proteomic Analysis of Plasma Samples from Chronic Hepatitis B and Chronic Liver Failure Patients for Biomarker Discovery"}